Gopal Badlani

About

Dr. Gopal Badlani is a pioneering urologic surgeon whose research has fundamentally reshaped the surgical management of benign prostatic hyperplasia (BPH), particularly for patients with large prostates. His key contributions center on the development and validation of Aquablation therapy, a minimally invasive robotic procedure that uses a high-velocity water jet to precisely remove obstructive prostate tissue. Dr. Badlani was instrumental in the landmark WATER II clinical trial, which demonstrated the long-term safety and efficacy of Aquablation for men with prostates between 80 and 150 mL—a population often requiring more invasive open surgery. The five-year results from this trial, published in 2023, have been cited nearly 50 times, underscoring their impact on clinical practice. His earlier foundational work, including the 2009 Society of Urologic Robotic Surgeons guidelines on training and credentialing for robotic urological surgery, has amassed over 240 citations and established critical safety standards for the field. Through rigorous subgroup analyses, Dr. Badlani has also shown that Aquablation offers superior symptom relief and a lower risk of ejaculatory dysfunction compared to traditional transurethral resection. His research continues to drive innovation in urology, offering patients safer, more effective options for BPH treatment.

Research Focus

Key Achievements

Top Papers

1. 1
   Training, Credentialing, Proctoring and Medicolegal Risks of Robotic Urological Surgery: Recommendations of the Society of Urologic Robotic Surgeons

   240 citations · 2009
2. 2
   Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results

   63 citations · 2019
3. 3
   Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results

   49 citations · 2023
4. 4
   Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial

   42 citations · 2018
5. 5
   WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm3 and 80–150-cm3 Prostates

   25 citations · 2021
6. 6
   Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results.

   24 citations · 2020
7. 7
   Functional and surgical outcomes of Aquablation in elderly men

   16 citations · 2022
8. 8
   Update on Lower Urinary Tract Symptoms

   2 citations · 2009

Key Collaborators

Contact & Links